» Articles » PMID: 36176915

Therapeutic Potential of Traditional Chinese Medicine for the Treatment of NAFLD: A Promising Drug Bunge

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2022 Sep 30
PMID 36176915
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive accumulation of hepatic lipids and metabolic stress-induced liver injury. There are currently no approved effective pharmacological treatments for NAFLD. Traditional Chinese medicine (TCM) has been used for centuries to treat patients with chronic liver diseases without clear disease types and mechanisms. More recently, TCM has been shown to have unique advantages in the treatment of NAFLD. We performed a systematic review of the medical literature published over the last two decades and found that many TCM formulas have been reported to be beneficial for the treatment of metabolic dysfunctions, including Bunge (PDB). PDB has a variety of active compounds, including flavonoids, terpenoids, organic acids, steroids and tannins. Many compounds have been shown to exhibit a series of beneficial effects for the treatment of NAFLD, including anti-oxidative and anti-inflammatory functions, improvement of lipid metabolism and reversal of insulin resistance. In this review, we summarize potential therapeutic effects of TCM formulas for the treatment of NAFLD, focusing on the medicinal properties of natural active compounds from PDB and their underlying mechanisms. We point out that PDB can be classified as a novel candidate for the treatment and prevention of NAFLD.

Citing Articles

Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future.

Zhang W, Wang M, Xie C World J Gastroenterol. 2024; 30(43):4597-4601.

PMID: 39575403 PMC: 11572638. DOI: 10.3748/wjg.v30.i43.4597.


A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases.

Yang C, Wu Y, Qian J, Li J Acta Pharm Sin B. 2024; 14(10):4228-4242.

PMID: 39525586 PMC: 11544391. DOI: 10.1016/j.apsb.2024.05.011.


Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway.

Niu M, Dong G, Li Y, Luo Q, Cao L, Wang X World J Gastroenterol. 2024; 30(30):3584-3608.

PMID: 39193572 PMC: 11346146. DOI: 10.3748/wjg.v30.i30.3584.


Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis.

Zhang P, Cao J, Liang X, Su Z, Zhang B, Wang Z Acta Biochim Biophys Sin (Shanghai). 2024; 56(4):621-633.

PMID: 38516704 PMC: 11090856. DOI: 10.3724/abbs.2024025.


Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies.

Ding X, He X, Tang B, Lan T Chin Med. 2024; 19(1):21.

PMID: 38310315 PMC: 10838467. DOI: 10.1186/s13020-024-00894-1.


References
1.
Liu X, Pan Q, Cao H, Xin F, Zhao Z, Yang R . Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease. Hepatology. 2019; 72(2):454-469. PMC: 10465073. DOI: 10.1002/hep.31050. View

2.
Yang J, Sun Y, Wang M, Zhang X, Zhang S, Gao Y . Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World J Gastroenterol. 2019; 25(34):5105-5119. PMC: 6747291. DOI: 10.3748/wjg.v25.i34.5105. View

3.
Cheng F, Ma C, Wang X, Zhai C, Wang G, Xu X . Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study. BMC Complement Altern Med. 2017; 17(1):203. PMC: 5383977. DOI: 10.1186/s12906-017-1707-2. View

4.
Zang Y, Zhang L, Igarashi K, Yu C . The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice. Food Funct. 2015; 6(3):834-41. DOI: 10.1039/c4fo00844h. View

5.
Duan L, Ding W, Liu X, Cheng X, Cai J, Hua E . Biosynthesis and engineering of kaempferol in Saccharomyces cerevisiae. Microb Cell Fact. 2017; 16(1):165. PMC: 5615808. DOI: 10.1186/s12934-017-0774-x. View